Dr. Glen Borchert

Chief Genetics Officer

  • Grey LinkedIn Icon

Dr. Borchert is Associate Professor of Pharmacology at
the University of South Alabama College of Medicine. He
completed a PhD in Interdisciplinary Genetics in 2007 at
the University of Iowa, then a postdoctoral fellowship at
UC Berkeley where he worked in the world’s foremost
genetic manipulation lab under Dr. Jennifer Doudna
(inventor of CRISPR-Cas9 genomic editing). Since starting
his own laboratory in 2012, Dr. Borchert has received
numerous awards, published >25 articles characterizing
genomes, and received >$3.5M in federal funding.
Notably, in 2014, the Genetic Mechanisms Cluster of the
National Science Foundation named Dr. Borchert a NSF
CAREER Investigator - the most prestigious honor
bestowed by the NSF. Dr. Borchert’s current research
focuses on identifying novel genes and genetic regulators
in an array of bacterial, plant, and animal systems.

Anthony Campbell

Chief Marketing Officer

  • Grey LinkedIn Icon

Anthony is well positioned to ensure the firm is ready to react to strategic growth opportunities in the health and wellness space. He brings a wealth of management consulting experience and expertise in global health sector management. Prior to joining GT Research, Anthony led product development and strategy formulations for top players in the global CPG industry from bench to shelf. Anthony holds a BSE in Chemical Engineering from the University of Michigan and an MBA from Duke University, The Fuqua School of Business, with a concentration in Health Sector Management.

Michael Francis

Chief Science Officer

  • Grey LinkedIn Icon

Dr. Francis is Chief Science Officer at GT Research and Assistant Professor of Physiology and Cell Biology at the University of South Alabama College of Medicine and Center for Lung Biology. Dr. Francis is an experienced research scientist with extensive knowledge of genomics, biophysics, and computational analytics, receiving ~$1M in grant funding. Dr. Francis also maintains a portfolio of intellectual property, including software platforms for medical devices and signal analytics. Dr. Francis manages project topsoil, GTR’s proprietary bioinformatics and genomics research platform, and project cloudscape,
GTR’s proprietary natural language processing platform for scientific literature. Dr. Francis earned a BSc in Physics from Auburn University and a PhD in Physiology from the University of South Alabama.

Danny Proctor

Chief Growth Officer

  • Grey LinkedIn Icon

A long-time investment practitioner and horticulturalist, Danny handles operations, project management, and execution for GTR. His professional experience includes oversight and execution of complex environmental and construction projects. Danny has overseen all aspects of crop production and sale on multi-acre organic farms in California and Montana. He holds a BA in Government and Law and a BA in Spanish from Lafayette College.

Sam Proctor

Chief Executive Officer

  • Grey LinkedIn Icon

Sam is Founder and CEO of GTR. He is also Co-Founder of Genesis Block, a blockchain- focused venture production studio. Prior to founding GTR, Sam was an attorney at Debevoise & Plimpton LLP, where he focused his practice on complex financial services regulation. Sam holds a JD from the University of Chicago Law School and a BSE from the Wharton School of the University of Pennsylvania, where he was a Benjamin Franklin Scholar and a Joseph Wharton Scholar.